Qual é o preço para BillionToOne, Inc. (BLLN)

O preço para BillionToOne, Inc. (BLLN) é $99.89

Qual é a capitalização de mercado para BillionToOne, Inc. (BLLN)

A capitalização de mercado para BillionToOne, Inc. (BLLN) é $4.59B

Receita de BillionToOne, Inc. (BLLN)

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Ano	Receita	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Receita

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Receita	Diferença de Receita	País
Thermo Fisher Scientific Inc. TMO.US	$46.34B	-	US
Danaher Corporation DHR.US	$25.11B	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$2.71B	-	US
Agilent Technologies, Inc. A.US	$7.23B	-	US

Empresa

Receita

Diferença de Receita

País